As of 2025-04-21, the Relative Valuation of ALX Oncology Holdings Inc (ALXO) is (59.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of ALX Oncology Holdings Inc based on Relative Valuation is -10893.9%.
The range of the Relative Valuation is (46.74) - (68.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 32.0x | 25.2x |
| Forward P/E multiples | 16.5x - 27.0x | 21.8x |
| Fair Price | (46.74) - (68.21) | (59.37) |
| Upside | -8597.3% - -12501.5% | -10893.9% |
| Date | P/E |
| 2025-04-09 | -0.20 |
| 2025-04-08 | -0.20 |
| 2025-04-07 | -0.21 |
| 2025-04-04 | -0.20 |
| 2025-04-03 | -0.21 |
| 2025-04-02 | -0.24 |
| 2025-04-01 | -0.24 |
| 2025-03-31 | -0.25 |
| 2025-03-28 | -0.26 |
| 2025-03-27 | -0.28 |
| 2025-03-26 | -0.27 |
| 2025-03-25 | -0.28 |
| 2025-03-24 | -0.27 |
| 2025-03-21 | -0.28 |
| 2025-03-20 | -0.30 |
| 2025-03-19 | -0.31 |
| 2025-03-18 | -0.29 |
| 2025-03-17 | -0.31 |
| 2025-03-14 | -0.33 |
| 2025-03-13 | -0.33 |
| 2025-03-12 | -0.38 |
| 2025-03-11 | -0.39 |
| 2025-03-10 | -0.35 |
| 2025-03-07 | -0.42 |
| 2025-03-06 | -0.52 |
| 2025-03-05 | -0.41 |
| 2025-03-04 | -0.40 |
| 2025-03-03 | -0.41 |
| 2025-02-28 | -0.44 |
| 2025-02-27 | -0.42 |
| 2025-02-26 | -0.42 |
| 2025-02-25 | -0.42 |
| 2025-02-24 | -0.42 |
| 2025-02-21 | -0.44 |
| 2025-02-20 | -0.44 |
| 2025-02-19 | -0.47 |
| 2025-02-18 | -0.47 |
| 2025-02-14 | -0.44 |
| 2025-02-13 | -0.43 |
| 2025-02-12 | -0.42 |
| 2025-02-11 | -0.41 |
| 2025-02-10 | -0.41 |
| 2025-02-07 | -0.43 |
| 2025-02-06 | -0.48 |
| 2025-02-05 | -0.49 |
| 2025-02-04 | -0.51 |
| 2025-02-03 | -0.52 |
| 2025-01-31 | -0.58 |
| 2025-01-30 | -0.52 |
| 2025-01-29 | -0.58 |